Biosimilar Newsletter Archive
-
03.16.23 -- Sandoz To Build New Biologics Plant In Slovenia
3/16/2023
03/16/23 Biosimilar Development Newsletter
-
03.09.23 -- Protect Your Drug By Setting High Standards For Your Packaging
3/9/2023
03/09/23 Biosimilar Development Newsletter
-
03.09.23 -- FDA, FTC Collaborate To Advance Biologics Competition
3/9/2023
03/09/23 Biosimilar Development Newsletter
-
03.06.23 -- Resources To Help You Assess Your Current Level Of Digital Automation
3/6/2023
03/06/23 Biosimilar Development Newsletter
-
03.02.23 -- 6 Strategies To Protect Your Biologics Supply Chain In 2023
3/2/2023
03/02/23 Biosimilar Development Newsletter
-
03.01.23 -- 6 Risk-Mitigating Solutions For Your Biologic's Development
3/1/2023
03/01/23 Biosimilar Development Newsletter
-
02.23.23 -- EMA's Revised GMP Annex 1 Addresses Common Global Challenges For Sterile Products
2/23/2023
02/23/23 Biosimilar Development Newsletter
-
02.21.23 -- Improve Your Productivity With The Use Of Effective Modular Systems
2/21/2023
02/21/23 Biosimilar Development Newsletter
-
02.16.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation
2/16/2023
02/16/23 Biosimilar Development Newsletter
-
02.09.23 -- First Humira Biosimilar Now Available In U.S.
2/9/2023
02/09/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more